Key facts
- Behrenbruch Christian has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $310,357,568.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Behrenbruch Christian
- Location
- North Melbourne, Australia
- Summary
- The estimated net worth of Behrenbruch Christian is at least $310,357,568 dollars as of 06 May 2026. Behrenbruch Christian is the MD & Group CEO, Director of Telix Pharmaceuticals Ltd and owns shares of Telix Pharmaceuticals Ltd (TLX) stock worth about $310.36M.
- Signature
- /s/ Oliver Newman, on behalf of Dr. Christian Behrenbruch, MD & Group CEO
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Behrenbruch Christian and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Telix Pharmaceuticals Ltd ($310,357,568).
- Past-year value change for that position: +$996,738.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Behrenbruch Christian
TLX, TLPPF
Forms 3/4/5
Telix Pharmaceuticals Ltd
- Relationship
- MD & Group CEO, Director
- Holdings value
- $310,357,568
- Past year net change
- +$996,738
- Change %
- +0.32%
- Report period
- 28 Apr 2026
Insider Transactions Reported by Behrenbruch Christian:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.